Single-dose pharmacokinetic study of 0.03 mg/kg of oral R108512 solution in a minimum of 24 pediatric patients aged >= 4 to <= 12 years who are diagnosed with FFR. PK analysis will be performed for 72 hours post trial medication administration. Tolerability and safety of the trial medication will also be monitored.
Showing the most recent 10 out of 459 publications